438
Views
46
CrossRef citations to date
0
Altmetric
Original

Human intestinal P‐glycoprotein activity estimated by the model substrate digoxin

, , , , , , & show all
Pages 123-134 | Received 05 Apr 2006, Accepted 31 Aug 2006, Published online: 08 Jul 2009
 

Abstract

Objective. P‐glycoprotein (Pgp) plays a part in the intestinal uptake of xenobiotics and has been associated with susceptibility to ulcerative colitis. The aim of this study was to examine Pgp activity in relation to age, gender, medical treatment (rifampicin or ketoconazole) and the multidrug resistance (MDR1) gene single nucleotide polymorphisms (SNPs) G2677T and C3435T using the model drug digoxin. Material and methods. Pgp activity was estimated from the pharmacokinetics of orally administered digoxin in blood samples from 32 healthy subjects. MDR1 gene expression in duodenal biopsies was monitored by real‐time quantitative RT‐PCR (RQ‐PCR) and Western blot analyses. MDR1 SNPs were determined by PCR‐restriction fragment length polymorphism (PCR‐RFLP). The effect of medical treatment was tested by open, randomized, cross‐over treatment with rifampicin and ketoconazole. Results. Rifampicin treatment resulted in increased Pgp activity, duodenal MDR1 mRNA expression and Pgp detection compared with that in the control group (p<0.05 for all), Pgp activity being associated with duodenal MDR1 mRNA level (p<0.05). Individuals homozygous for the 3435 wild‐type allele (CC) showed higher Pgp activity (p<0.05), whereas SNP 2677 apparently did not affect Pgp activity. No variation in Pgp in relation to age or gender was found. Conclusions. Our data confirm that rifampicin increases Pgp activity, by increasing MDR1 mRNA and Pgp levels. Moreover, we found that the wild‐type allele of the synonymous polymorphism of MDR1 position 3435 confers a higher Pgp activity. These data support other findings suggesting an effect of Pgp on treatment response and disease susceptibility.

Acknowledgements

We thank the staff at Viborg County Hospital for practical help. We also express our thanks to Professor Peter Hokland for invaluable scientific discussions. The project was funded by the Lundbeck Foundation, the Danish Research Council, the Western Danish Research Forum for Health Science, County of Viborg, and the AP Møller and Chastine McKinney Møller Foundation. The Western Danish Research Forum for Health Science also contributed with statistical assistance.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.